# Xeris Pharmaceuticals

Xeris Pharmaceuticals is a Biopharmaceutical based in Tokyo, Japan.

## Overview

- **Organization type:** Biopharmaceutical
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** Tokyo, Japan
- **Founded:** 2005
- **Assets under management:** Undisclosed
- **Website:** http://www.xerispharma.com
- **LinkedIn:** https://www.linkedin.com/company/xeris-pharmaceuticals

## Regulatory record

- **Reports private funds:** No

## About

Xeris Pharmaceuticals is a pharmaceutical company based in Chicago, United States, founded in 2005. It develops and commercializes ready-to-use, liquid-stable injectables using its novel formulation technology platforms. The company has secured $115.5 million in total funding.

## Sectors

- Pharmaceuticals
- Biotech
- Healthcare Services

## Offices

- Chicago, United States

## Questions

### How is Xeris Pharmaceuticals structured?

Public records indicate the firm operates from Japan and the United States, but its legal structure — whether as a family office, asset manager, or holding company — is not specified in available sources.

### Who are the key principals at Xeris Pharmaceuticals?

No named principals or leadership team members for Xeris Pharmaceuticals are available in public sources. The firm's management structure remains undisclosed.

## Related profiles

- [Meta Materials Inc](https://altss.com/profile/meta-materials-inc)
- [Virtuozzo International GmbH](https://altss.com/profile/virtuozzo-international-gmbh)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/xeris-pharmaceuticals

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology